1 / 13

Votrient 400MG TABLET | Pazopanib | Apple pharmaceuticals

Votrient 400Mg tablet is used to treat certain other types of cancer (soft tissue sarcoma), <br>kidney cancer etc.It works by decreasing the blood supply to the cancer tumor to slow tumor <br>growth@ myapplepharma

Emimadi
Download Presentation

Votrient 400MG TABLET | Pazopanib | Apple pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Votrient400mg Tablets| Pazopanib400mg   Apple pharmaceuticals

  2. Votrient 400mg Tablet(Pazopanib 400mg) • Votrient 400mg is a type of protein kinase inhibitors, the main ingredient which is used as pazopanib. • It is also indicated for the treatment of advanced kidney cancer and soft tissue sarcoma Votrient 400mg is an antineoplastics medications which interfere with the development and spreadness of cancer cells in the body.

  3. USAGE • VOTRIENT 400MG is used as a single agent to treat the renel cell carcinoma and its advanced stage It works by preventing the activity of proteins which are interferes with the growth and spread of cancer cells. • Votrient400mg is also used as a single regimen to treat the Soft Tissue Sarcoma, (a type of cancer that occurs in the supportive tissue of the body). The cancer can develop in muscles, blood vessels, fat tissue or in other tissues that support, surround and protect organs

  4. PHARMACOLOGY • Votrient 400mg belongs to an inhibitor of potent protein kinase and selective multiple receptor tyrosine kinases (RTKs) which are described in beginning of signal transduction pathways that ready for proliferation of tumor cells and affect growth critical to cell continuity and tumor progression. • RTKs comes in the blockage and involves the receptors for vascular endothelial growth factors (VEGFR-1, -2, and -3), platelet-derived growth factors (PDGFR-α and -β), and stem cell factor.

  5. DOSAGE AND ADMINISTARTION • Votrient dosage for renal cell carcinoma and soft tissue sarcoma (cancer in joints, muscle) will be initially 800mg , the dose adjustment in 200mg increments or decrements dose based on tolerance but max dose in adult is 800mg/day. Moderate total bilirubin >1.5 to 3 times, Votrient dose of 200mg once daily.  • Votrientshould be taken on a empty stomach (1hr before or 2hr after meals. Swallow the medicine whole don’t chew/crush. Food interaction :Avoid grapefruit juice or grapefruit juice.

  6. PHARMACOKINETICS Absorption: • GI tract partially absorbed, votrient with food has greater absorption Bioavailability is 14-39%. Duration of peak plasma concentration: 2-4 hr. Distribution: • The drug Votrient 400mg has Human Plasma binding is >99%. Metabolism: • Mainly in the liver the drug metabolized and by CYP3A4 enzyme and to a lesser extent by CYP1A2 and CYP2C8 enzymes.

  7. PRECAUTION • Consult the doctor before to the treatment of Votrient 400mg tablets about: • Allgeric to pazopanib or any other drug products of pazopanib, which include in prescription, over the counters,vitamins,herbal remedies. Do not take immunization or vaccination without doctors advice. Inform your doctor about pregnancy and planning to pregnant. • Do not breast feed while treatment with Votrient

  8. MISSED DOSE • The drug dose is missed, and then takes the drug dose as soon as possible. • If time to next dose reaches then leave the missed dose and follow the routine schedule. • Do not have2 dose at one time. • Please consult your doctor for further clarification.

  9. DRUG INTERACTION • Strong CYP3A4 enzyme inhibitors (e.g. ketoconazole, itraconazole, voriconazole,etc) + Votrient 400mg → Increase plasma concentration. • Votrient + simvastatin → increases incidence of ALT elevation. • Votrient 400mg + PPI e.g. esomeprazole → decreases bioavailability. • Concurrent use of strong of BCRP inhibitors or P-gp (e.g. lapatinib) and inducers + Votrient 400mg →alter the exposure and distribution of pazopanib. • Votrient 400mg + rifampin(strong CYP3A4 Enzyme inducers) →decreases the plasma concentration.

  10. SIDE EFFECTS • Votrient400mg has certain side effects, If any of the symptoms occrs or not cured then call the doctor immediately Major side effects: • Diarrhae; High blood pressure; low WBC; Elevated liver function test; Blood test abnormalities; increased in bilirubin levels. • Common Side effects: Nausea; loss of appetite; fatigue; blood test abnormalities (low magnesium, low glucose); weakness, stomach ache.

  11. LACTATION • Votrient400mg usage is not usually given during in pregnant women and the some doctors advice to either discontinue breastfeeding or the drug, in order to give importance of drug to the mother. The drug elimination into human milk • effects in the newborn baby is unknown.

  12. OVERDOSAGE • there is no specific antidote for Votrient overdose, the drug doses upto 2000 mg can be administrated and It is check out in clinical trials and overdose treatment with votrient should consist of supportive measures.

  13. Contact Us • phone No      :9987711567 • Email             :info@myapplepharma.com website          • https://myapplepharma.com/pazopanib-400mg.php

More Related